BlossomHill Therapeutics Funding: $173M Raised, Series B
BlossomHill Therapeutics is a Biotech company based in San Diego, CA. It has raised $173M in total funding. Latest round: Series B.
BlossomHill Therapeutics funding overview
BlossomHill Therapeutics is a Biotech company based in San Diego, CA. BlossomHill Therapeutics has raised $173M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in December 2025. The round record for BlossomHill Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Colt Ventures, Cormorant Asset Management, OrbiMed, Vivo Capital, Janus Henderson Investors, Brahma Capital and 4 others. 10 distinct backers are named across the disclosed rounds.
BlossomHill Therapeutics at a glance
Total raised
$173M
Latest round
Series B
Latest round date
December 2025
Industry
Biotech
Headquarters
San Diego, CA
Notable investors
Colt Ventures, Cormorant Asset Management, OrbiMed, Vivo Capital, Janus Henderson Investors, Brahma Capital, BioTrack Capital, Plaisance Capital Management LLC
Frequently asked about BlossomHill Therapeutics funding
How much has BlossomHill Therapeutics raised?
BlossomHill Therapeutics has raised $173M in total disclosed funding across the rounds on record.
Who has invested in BlossomHill Therapeutics?
Colt Ventures, Cormorant Asset Management, OrbiMed, Vivo Capital, Janus Henderson Investors, Brahma Capital are named among the investors backing BlossomHill Therapeutics.
What was the latest BlossomHill Therapeutics funding round?
The most recent disclosed round is a Series B, announced in December 2025.
Where is BlossomHill Therapeutics based?
BlossomHill Therapeutics is based in San Diego, CA.
What sector does BlossomHill Therapeutics operate in?
BlossomHill Therapeutics is tracked under Biotech from San Diego, CA, with $173M in disclosed funding.
When did BlossomHill Therapeutics last raise?
The last disclosed BlossomHill Therapeutics round closed in December 2025 at Series B.
Totals shown for BlossomHill Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in San Diego and the investors behind them below.
Companies related to BlossomHill Therapeutics (37)
